10-K/A XBRL

10-K/A Filing

Company: Protagenic Therapeutics, Inc.\new
Filed: April 17, 2023
Period of Report: December 31, 2022
Accession Number: 0001493152-23-012498

View Document ↗ View on SEC.gov ↗